$SNY News

Last published 3w ago

3w agoSNYScionxBio Announces Collaboration to Develop Long-Acting xRNA TherapeuticsBusiness WireScionxBio (the "company", operating as a brand identity of Eleven Therapeutics Ltd. following a horizontal split) a privately held, preclinical-stage biotechnology company pioneering next-generation mRNA
4w agoHYFT GENB MRNA ABSI+1AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next TestGlobeNewswireNews Provided by Biotech Insider on behalf of MindWalk Holdings Corp. BOSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Biotech Insider News Commentary - For most of the past decade, the promise of AI in drug discovery was
1mo agoSNYSanofi and 2026 NBA Champion Karl-Anthony Towns team up to raise awareness of COVID-19 vaccination with NUVAXOVID®PR NewswireSanofi has partnered with 2026 NBA Champion Karl-Anthony Towns to help raise awareness about the importance of COVID-19 vaccination among those...
2mo agoQNTM SNY RHHBY BIIB+1A Micro-Cap Biotech Just Cleared a Milestone Most Never ReachGlobeNewswireAUSTIN, Texas, Sept. 08, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Multiple sclerosis ("MS") drugs on the market today can slow the disease down, but none of them stop it, and none of them give
2mo agoSNYSanofi and Keke Palmer team up to urge parents to help protect babies from serious RSV with BEYFORTUS®PR NewswireSanofi is partnering with Emmy Award-winning actress, entrepreneur and mom Keke Palmer to help educate families about the importance of protection...
2mo agoAZN REGN SNY GSKAstraZeneca's COPD drug scores two late-stage trial wins as full data boosts blockbuster hopesCNBCThe full data reinforces hopes that the drug could be a breakthrough COPD treatment and reach AstraZeneca's peak annual sales forecast of more than $5 billion.
4mo agoQNTM SNY RHHBY BIIB+1Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple SclerosisGlobeNewswireAUSTIN, Texas, June 22, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Multiple sclerosis ("MS") robs people of control over their own bodies — slowly, relentlessly and without a cure. More than 2.9
5mo agoSNYGoldman Sachs 47th Annual Global Healthcare Conference - RegeneronEarnings Call TranscriptsGood afternoon, everyone. Thank you so much for joining us. Really pleased to have with us the Regeneron team. Next to me is Chris Finemore, CFO, Andres Zirulnik, SVP Clinical Development Unit, Head of Hematology, and Ry
5mo agoSNYThe Nucleus Podcast_Ep. 6_Full Video - RGCEarnings Call TranscriptsHello and welcome everyone. My name is Sibloan Gil-Astrat. I am a director at the Immunology and Inflammation Department at Regeneron, and this is The Nucleus by RegenerOn, a podcast where we talk about science that intr
6mo agoSNY SANOFI2026 GLOBAL HEALTHCARE CONFERENCESANOFIEarnings Call TranscriptsOkay, guys, thank you for joining us. Welcome back to the Bank of America Healthcare Conference. It's my pleasure to have with me our next presenting company, Regeneron Pharmaceuticals. Up here on stage with me are two m
6mo agoSNY SANOFIRegeneron Pharmaceuticals Q1 2026 Earnings Conference CallSANOFIEarnings Call TranscriptsWelcome to the Regeneron Pharmaceuticals first quarter 2026 earnings conference call. My name is Kevin and I'll be your operator for today's call. At this time, all participants are on a listen-only mode. Later, we will
6mo agoSNY SANOFIRegeneron Investor Roundtable April 2026SANOFIEarnings Call TranscriptsWelcome to Regeneron's conference call to discuss its C5 Compliment Development Program. My name is Shannon, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later,
8mo agoSNYSanofi announces leadership evolution in Specialty Care Business UnitPR NewswireSanofi today announced the appointment of Manuela Buxo as Head of Specialty Care, effective March 1, 2026. Manuela will succeed Brian Foard, who has...
9mo agoSNY SANOFIRegeneron Pharmaceuticals Q4 2025 Earnings Conference CallSANOFIEarnings Call TranscriptsWelcome to the Regeneron Pharmaceuticals 4th Quarter 2025 Earnings Conference Call. My name is Shannon, and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we wi
9mo agoPFE NVO SNY AZN+2Drug pricing, patent losses and deals: Here's what pharma execs see ahead in the industryCNBCBig pharma is grappling with new drug pricing deals and roughly $300 billion in potential lost revenue from patent expirations of blockbuster drugs.
10mo agoSNY SANOFIThe Nucleus Ep. 7 - SANOFIEarnings Call TranscriptsHello, and welcome everyone to the Nucleus by Regeneron, a podcast where we invite our guests to discuss the science that gets us out of bed in the morning. I'm Will Salerno, Executive Director of Genome Informatics and
10mo agoGSK MRK BMY AMGN+7Nine of the largest pharma companies ink deals with Trump to lower drug pricesCNBCPresident Donald Trump has pushed to lower drug prices for Americans, which are on average nearly three times higher than overseas.
11mo agoSNYDren Bio Expands Strategic Collaboration with Sanofi to Develop Next-Generation B-Cell Depletion TherapyBusiness Wire– New collaboration builds on Sanofi's prior acquisition of DR-0201 and further leverages Dren Bio's proprietary Targeted Myeloid Engager and Phagocytosis Platform to discover first-in-class multispecific antibody
11mo agoABBV JNJ LLY SNYVida Ventures Marks Fourth Major Portfolio Acquisition in 2025, Capping a Record-Setting Year for Its Science-Led, Discipline-Driven StrategyBusiness WireHalda Therapeutics acquired by Johnson & Johnson for $3.05 billion – the largest acquisition ever across any therapeutic area for a Phase 1 company Scorpion Therapeutics acquired by Eli Lilly for Up to $2.5
1y agoSNYEVOQ Therapeutics Announces Collaboration and License Agreement with SanofiPR NewswireEVOQ Therapeutics, Inc. (EVOQ), a biotechnology company focused on delivering transformative cures for those living with autoimmune diseases, today...
1y agoSNYITM Appoints Annette Breunig as Chief People OfficerGlobeNewswireGlobal HR leader to drive ITM's long-term human resources strategy, support organizational development and corporate growth Garching / Munich, Germany, October 13, 2025 – ITM Isotope Technologies Munich SE (ITM), a
1y agoRVTY SNYRevvity Announces Program to Revolutionize the Early Detection of Type 1 DiabetesBusiness WireInitiative spans an IVD assay and a new Revvity Omics lab-developed test to expand clinical testing for early-stage disease screening Revvity, Inc. (NYSE:RVTY) today announced a program for expansion of its type 1
1y agoSNYSanofi expands patient affordability program by offering access to all its insulins for $35 per month in the USPR NewswireSanofi US today announces a broad expansion of its Insulins Valyou Savings Program by offering a 30-day supply of any Sanofi insulin for $35 to all...
1y agoSNYMandy Moore and Celebrity Mom Squad join Sanofi to help protect babies from RSV with BEYFORTUS®PR NewswireSanofi is partnering with celebrity moms who chose to immunize their babies with BEYFORTUS® (nirsevimab-alip) to help educate families about the...
1y agoSNYSanofi (SNY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptEarnings Call Transcripts
1y agoSNYSanofi (SNY) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
1y agoABBV AMGN AZN BMY+10Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 daysCNBCTrump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo Nordisk.
1y agoABBV BMY LLY NVS+14Trump's pharmaceutical tariffs could affect some drugmakers more than othersCNBCAbbVie, Bristol Myers Squibb and Eli Lilly appear "relatively well-positioned," while Novartis and Roche look more at risk, TD Cowen analyst Steve Scala said.
1y agoSNYU.S. to remove mercury preservative from flu shots following RFK Jr. vaccine panel voteCNBCWhile few shots still contain thimerosal, the move eliminates a vaccine option for Americans and is a win for the anti-vaccine movement.
1y agoADAG SNYAdagene announces up to $25 million strategic investment from SanofiGlobeNewswire- Sanofi to exercise option on third SAFEbody discovery program and sponsor combination clinical trial with muzastotug - Company expects proceeds to extend cash runway into 2027 SAN DIEGO and SUZHOU, China, July - Sanofi to exercise option on third SAFEbody di
1y agoMRK SNY AZNRFK Jr.'s CDC vaccine panel backs Merck RSV shot for infantsCNBCThe votes in favor of Merck's shot are a sigh of relief after Kennedy gutted the panel and tapped replacements, some of whom are well-known vaccine critics.
1y agoSNYSanofi awards Healthy Futures Solution Fund grants to advance community-led solutions, expand equitable access to care across MassachusettsPR NewswireSanofi today announced it has awarded over $1 million in grants through its inaugural Healthy Futures Solution Fund to support local nonprofits...
1y agoSNYSobi will showcase extensive research and clinical outcomes at ISTH 2025PR NewswireSobi® (STO: SOBI) will be presenting a wide range of clinical study updates at the annual International Society on Thrombosis and Haemostasis (ISTH)...
1y agoSNYRFK Jr.'s new vaccine advisors will vote on flu shots containing mercuryCNBCIt is the panel's first meeting with Kennedy's newly appointed members, many of whom are well-known vaccine critics.
1y agoMRK SNY AZN-GB PFE+2FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZenecaCNBCMerck's shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.
1y agoSNYSanofi opens new, $130 million NJ offices in Morristown, showcasing innovative, modern design and strengthening US presencePR NewswireSanofi today announces the formal opening of the company's new flagship US offices, unveiling a state-of-the-art modern workplace fostering...
1y agoSNY VIGLVigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by SanofiGlobeNewswire- Vigil's shareholders to receive up to $10.00 per share in cash, comprised of $8.00 per share in cash at closing and a non-tradeable contingent value right of $2.00 per share in cash following the first commercial sale
1y agoREGN SNYViz.ai Announces Collaboration With Sanofi and Regeneron to Improve Management and Care of Chronic Obstructive Pulmonary Disease (COPD)Business WireCompanies will collaborate on an AI-powered care improvement solution for patients with high-risk COPD Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a multi-year
1y agoSNYSanofi to invest at least $20 billion in the US through 2030, growing investments in science and expanding domestic manufacturingPR NewswireSanofi today announces its intention to invest at least $20 billion in the United States through 2030. The expected investment includes a significant ...
1y agoSNYSobi and Sanofi's Foundation S extend partnership with the World Federation of Hemophilia Humanitarian Aid ProgramPR NewswireSobi® (STO: SOBI) together with the World Federation of Hemophilia (WFH) and Sanofi, through its philanthropic organisation Foundation S, announced...
1y agoDVAX MRNA SNY TARS+4Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow ShareholdersBusiness WireBelieves Company's Misguided Acquisition Strategy is Destroying Value and Preventing Dynavax from Maximizing the Opportunities of Heplisav for Shareholders and Patients In Deep Track's View, Properly Focusing on
1y agoSNYChrissy Teigen - author, entrepreneur, mom to young son with type 1 diabetes - joins Sanofi's Screen For Type 1 movementPR NewswireSanofi, a leader in diabetes care, welcomes author, entrepreneur, and mom Chrissy Teigen as its new celebrity spokesperson for the Screen For Type 1...
1y agoSNYSanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu seasonPR NewswireSanofi announced today the immediate adoption of influenza strains selected by the US Food and Drug Administration (FDA) to advance the manufacturing ...
1y agoAVTE DVAX HZNP MRNA+7Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies' Board of Directors at 2025 Annual MeetingBusiness WireIssues Letter to Fellow Shareholders Detailing Why Truly Independent Voices – Including a Shareholder Representative – Are Needed in the Dynavax Boardroom
1y agoMRNA SNY NVAXModerna stock plunges 18% after company lowers 2025 sales forecast by $1 billionCNBCModerna now expects 2025 revenue to come in between $1.5 billion and $2.5 billion, most of which will come in the second half of the year.
2y agoSNYSanofi (SNY) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
2y agoMRK SNY AZN PFEMerck says experimental RSV shot protected infants in trial, paving way for potential approvalCNBCMerck is discussing the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season.
2y agoSNYFLUBLOK® (Influenza Vaccine) US label updated with one of Sanofi's largest flu vaccine safety studies in pregnant individualsPR NewswireThe U.S. Food and Drug Administration (FDA) has updated the label for FLUBLOK (Influenza Vaccine) to include data from a new safety study involving...
2y agoSNYSanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studiesPR NewswireSanofi announced today it will contribute $18 million to three Historically Black Medical Schools to help the institutions work to increase diversity ...
2y agoSNYSanofi (SNY) ECTRIMS 2024 Investor Science Call TranscriptEarnings Call Transcripts